US 10696713
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 10696713 (Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P13/12, A61P3/00